This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
VEDBAEK, Denmark, July 8, 2013 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value products for gene expression analysis, today announced that Frost & Sullivan has recognized Exiqon as the recipient of the 2013 Company of the Year Award in Global microRNA Research Tools in light of the excellence that Exiqon has exhibited in the microRNA research space. This award follows Frost & Sullivan's most recent analysis of the global microRNA research tools and services market.
Exiqon was one of the first companies to commercially serve the microRNA market and scientists around the world have published thousands of peer-reviewed scientific papers based on Exiqon's microRNA research products since the first product introductions in 2005.
Most recently, Exiqon has developed a database search tool, miRSearch, which allows customers to do simple and intuitive searches across a dozen relevant databases and easily navigate the overwhelming amount of microRNA information when designing experiments. The search tool is accessible at
www.exiqon.com/mirsearch . This recent extension complements Exiqon's leading miRCURY LNA(tm) products for microRNA research that include validated microRNA products for sample extraction, gene expression and functional analysis, as well as advanced software for data analysis.
Exiqon has been cited as a preferred one-stop shop provider of complete workflow solutions pertaining to microRNA research. Provision of microRNA profiling and screening services along with products has not only simplified purchasing, but has also attracted new customers for Exiqon.
ver the past eight years, the microRNA research space has evolved from an exotic research field to an emerging market which includes validated biomarkers and clinical applications," says Exiqon CEO Lars Kongsbak. "
According to Frost & Sullivan analysis, Exiqon holds an average market share of 24 percent, thereby continuing to be instrumental in helping scientists across industry and academia understand and apply the biology of microRNAs".
Frost & Sullivan does not accept nominations or submissions for Frost & Sullivan Awards. The selection of this Award comes through in-depth interviews and primary market analysis conducted by Frost & Sullivan's industry analyst team.